This study will enroll 120 individuals diagnosed with subarachnoid cysticercosis, a disease
caused by the invasion of the basal part of your brain by a parasite named Taenia solium.
Subarachnoid cysticercosis is usually treated with albendazole for one month to kill the
parasite. This study will determine if two months of albendazole (ABZ) therapy is better than
one-month. The study will last 3 years.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)